When.com Web Search

  1. Ads

    related to: dangers of talc supplements chart for women over 60 big boned female

Search results

  1. Results From The WOW.Com Content Network
  2. Study links talc use to ovarian cancer — a potential boon for ...

    www.aol.com/news/study-links-talc-ovarian-cancer...

    At the very least, the findings should prompt women to rethink their use of talc products, said Katie O’Brien, the lead author of the analysis and an epidemiologist at the National Institute of ...

  3. Thousands of women plan legal action over alleged links ...

    www.aol.com/thousands-women-plan-legal-action...

    Tom Longstaff, a partner at KP Law, said: “All of the claimants, predominantly women but also some men, who have sustained cancer after using J&J’s talcum powder products have experienced a ...

  4. States settle $700 million lawsuit over allegedly harmful ...

    www.aol.com/states-settle-700-million-lawsuit...

    Talc was contained in popular Johnson & Johnson products such as baby powder and body powder. As part of the settlement reached with 42 states and the District of Columbia, Johnson & Johnson has ...

  5. Megavitamin therapy - Wikipedia

    en.wikipedia.org/wiki/Megavitamin_therapy

    The US Recommended Dietary Allowance for niacin for adult women is 14 mg/day and for adult men 16 mg/day. Niacin is available as a prescription product, either immediate release (500 mg tablets; prescribed up to 3,000 mg/day) or extended release (500 and 1,000 mg tablets; prescribed up to 2,000 mg/day).

  6. List of herbs with known adverse effects - Wikipedia

    en.wikipedia.org/wiki/List_of_herbs_with_known...

    female ginseng Angelica sinensis: May induce uterine contractions; contraindicated when pregnant or nursing [14] European Mistletoe: common mistletoe Viscum album: Toxic to cardio and central nervous systems, gastrointestinal bleeding [3] Ephedra: ma huang: Ephedra sinica

  7. Centrum (multivitamin) - Wikipedia

    en.wikipedia.org/wiki/Centrum_(multivitamin)

    No statistically significant effects were found for any specific cancers or cancer mortality. The 95% CI of the hazard ratio implied a benefit of between 14% and .2% over placebo. In absolute terms the difference was 1.3 cancer diagnoses, per 1000 years of life (18.3-17 events, respectively). The median follow up time was 11.2 years. [3]